Erasca (ERAS) Profit After Tax Growth (1y) (2021 - 2026)
Erasca (ERAS) Profit After Tax Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
PAT Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
-88.68% |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
66.06% |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
17.05% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
-290.15% |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
-129.68% |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
-632.44% |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
59.59% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Erasca |
4.28 Bn |
4.03 Bn |
- |
-492.39% |
| Date | Value |
|---|
| Mar 31, 2026 |
-492.39% |
| Dec 31, 2025 |
9.74% |
| Sep 30, 2025 |
1.88% |
| Jun 30, 2025 |
46.40% |
| Mar 31, 2025 |
11.57% |
| Dec 31, 2024 |
-8.52% |
| Sep 30, 2024 |
-2.76% |
| Jun 30, 2024 |
-98.86% |
| Mar 31, 2024 |
-5.48% |
| Dec 31, 2023 |
78.04% |
| Sep 30, 2023 |
14.45% |
| Jun 30, 2023 |
10.75% |
| Mar 31, 2023 |
8.94% |
| Dec 31, 2022 |
-343.97% |
| Sep 30, 2022 |
22.97% |
| Jun 30, 2022 |
-26.21% |
| Mar 31, 2022 |
-102.35% |
| Dec 31, 2021 |
50.79% |
| Sep 30, 2021 |
-334.29% |
| Jun 30, 2021 |
-413.82% |
